- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 76.43M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 77.27M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 76.58M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1.5M |
| Capex | Q1 2026 · Mar 31, 2026 | $41.65M |
| Capex | Q1 2026 · Mar 31, 2025 | $45.79M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $581.25M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $250M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $336.88M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $281.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$464.77M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$460.98M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $570.98M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $586.36M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.2B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $947.08M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.88B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.91B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $588.5M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $547.87M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.42B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.45B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.32 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.32 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $255.23M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $262.37M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.47M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$24.98M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $17.13M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $19.79M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $349.75M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $354.64M |
| Revenue | Q1 2026 · Mar 31, 2026 | $627.78M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $673.88M |